• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[The molecular pathogenesis of small cell lung cancer].

作者信息

D'Angelo Sandra P, Pietanza M Catherine

机构信息

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, NY, USA.

出版信息

Zhongguo Fei Ai Za Zhi. 2010 Nov;13(11):C46-57. doi: 10.3779/j.issn.1009-3419.2010.11.18.

DOI:10.3779/j.issn.1009-3419.2010.11.18
PMID:21081036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6134416/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/645a1ea12e47/zgfazz-13-11-C46-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/aab546b4bf3e/zgfazz-13-11-C46-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/d2cc88ec34d7/zgfazz-13-11-C46-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/2a10c6ab8695/zgfazz-13-11-C46-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/645a1ea12e47/zgfazz-13-11-C46-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/aab546b4bf3e/zgfazz-13-11-C46-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/d2cc88ec34d7/zgfazz-13-11-C46-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/2a10c6ab8695/zgfazz-13-11-C46-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28c1/6134416/645a1ea12e47/zgfazz-13-11-C46-4.jpg

相似文献

1
[The molecular pathogenesis of small cell lung cancer].[小细胞肺癌的分子发病机制]
Zhongguo Fei Ai Za Zhi. 2010 Nov;13(11):C46-57. doi: 10.3779/j.issn.1009-3419.2010.11.18.
2
MicroRNA-217 inhibits proliferation and promotes apoptosis of small cell lung cancer cells via targeting PCDH8.微小RNA-217通过靶向原钙黏蛋白8抑制小细胞肺癌细胞的增殖并促进其凋亡。
Panminerva Med. 2021 Mar;63(1):95-96. doi: 10.23736/S0031-0808.19.03674-7. Epub 2019 Jul 8.
3
Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment.鉴定SMARCAL1作为小细胞肺癌治疗的分子靶点。
Cancer Lett. 2024 Jun 28;592:216932. doi: 10.1016/j.canlet.2024.216932. Epub 2024 May 11.
4
Evaluation of role of Notch3 signaling pathway in human lung cancer cells.Notch3信号通路在人肺癌细胞中的作用评估。
J Cancer Res Clin Oncol. 2016 May;142(5):981-93. doi: 10.1007/s00432-016-2117-4. Epub 2016 Feb 2.
5
[Report of epidermal growth factor receptor mutation in a patient with combined small cell lung cancer].[一例小细胞肺癌合并表皮生长因子受体突变的报告]
Zhonghua Bing Li Xue Za Zhi. 2014 Jan;43(1):45-6.
6
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer.肺癌中新型EPHB4受体酪氨酸激酶突变与激酶组学通路分析
Sci Rep. 2015 Jun 15;5:10641. doi: 10.1038/srep10641.
7
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.对表皮生长因子受体（EGFR）突变的耐药性肺腺癌转化为小细胞肺癌过程中的RB基因缺失。
Nat Commun. 2015 Mar 11;6:6377. doi: 10.1038/ncomms7377.
8
The landscape of mA regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance.小细胞肺癌中mA调节因子的格局：分子特征、免疫肿瘤学特征及临床相关性。
Mol Cancer. 2021 Sep 27;20(1):122. doi: 10.1186/s12943-021-01408-5.
9
Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.内向整流钾通道Kir2.1（KCNJ2）的上调在miR-7和Ras/MAPK信号通路的调控下调节小细胞肺癌的多药耐药性。
Mol Cancer. 2015 Mar 12;14:59. doi: 10.1186/s12943-015-0298-0.
10
MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.miR-485-5p 通过靶向 Flotillin-2 抑制小细胞肺癌细胞的增殖、迁移和侵袭。
Bioengineered. 2019 Dec;10(1):1-12. doi: 10.1080/21655979.2019.1586056.

本文引用的文献

1
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.伊立替康和顺铂治疗后 c-Kit 阳性广泛期小细胞肺癌患者的伊马替尼维持治疗的 II 期临床试验。
Clin Lung Cancer. 2010 Jul 1;11(4):223-7. doi: 10.3816/CLC.2010.n.028.
2
The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.成纤维细胞生长因子受体抑制剂PD173074在体外和体内均能抑制小细胞肺癌的生长。
Cancer Res. 2009 Nov 15;69(22):8645-51. doi: 10.1158/0008-5472.CAN-09-1576. Epub 2009 Nov 10.
3
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer.
伊立替康、卡铂和贝伐珠单抗治疗广泛期小细胞肺癌患者的 II 期临床试验。
J Thorac Oncol. 2009 Dec;4(12):1555-60. doi: 10.1097/JTO.0b013e3181bbc540.
4
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501.顺铂联合依托泊苷及贝伐单抗治疗既往未治疗的广泛期小细胞肺癌的II期研究：东部肿瘤协作组E3501研究
J Clin Oncol. 2009 Dec 10;27(35):6006-11. doi: 10.1200/JCO.2009.23.7545. Epub 2009 Oct 13.
5
Targeting the IGF1 axis in cancer proliferation.靶向胰岛素样生长因子1轴在癌症增殖中的作用
Expert Opin Ther Targets. 2009 Oct;13(10):1179-92. doi: 10.1517/14728220903201702.
6
Targeting the phosphoinositide 3-kinase pathway in cancer.靶向癌症中的磷酸肌醇3-激酶通路。
Nat Rev Drug Discov. 2009 Aug;8(8):627-44. doi: 10.1038/nrd2926.
7
Targeting PI3K signalling in cancer: opportunities, challenges and limitations.靶向癌症中的PI3K信号通路：机遇、挑战与局限
Nat Rev Cancer. 2009 Aug;9(8):550-62. doi: 10.1038/nrc2664.
8
Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.沙利度胺联合化疗用于小细胞肺癌的抗血管生成治疗：一项随机、双盲、安慰剂对照试验
J Natl Cancer Inst. 2009 Aug 5;101(15):1049-57. doi: 10.1093/jnci/djp200. Epub 2009 Jul 16.
9
Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.小细胞肺癌中PIK3CA的致癌突变：化疗耐药肺癌的潜在治疗靶点途径。
Cancer Lett. 2009 Oct 8;283(2):203-11. doi: 10.1016/j.canlet.2009.03.038. Epub 2009 Apr 25.
10
Cancer vaccination with telomerase peptide GV1001.用端粒酶肽 GV1001 进行癌症疫苗接种。
Expert Opin Investig Drugs. 2009 May;18(5):687-94. doi: 10.1517/13543780902897631.